老年人和他们的护理人员对退院后药物管理的观点:一种定性研究
Brian S Wood1, Caroline Buse1, Joshua D Niznik1,2,3,4
1Division of Geriatric Medicine University of North Carolina School of Medicine Chapel Hill North Carolina USA.
Health science reports
|March 11, 2026
概括
老年人和护理人员在出院后经常遇到药物管理挑战,包括不清楚的沟通和处方问题. 改善药物沟通和获取至关重要,以减少住院后的伤害.
科学领域:
- 老年医学 老年医学
- 患者安全 患者安全
- 卫生沟通健康沟通
背景情况:
- 老年人在出院后面临着重要的药物管理挑战.
- 现有的研究强调了潜在的危害,但缺乏患者和护理人员的观点.
- 生活经验对于理解出院后的药物管理问题至关重要.
研究的目的:
- 探索老年人和他们的护理人员在医院出院后对药物管理的经验和担忧.
- 从患者和护理人员的角度来看,确定药物沟通,处方流程和药物获取方面的具体挑战.
- 为旨在改善老年人退院后药物安全性的干预提供信息.
主要方法:
- 进行了34次退院后的结构化采访,这些采访来自老年急性护理 (ACE) 部门的老年人和护理人员.
- 使用由一个跨专业老年医疗团队开发的问卷.
- 分析了与药物沟通,处方和获取相关主题的采访数据.
主要成果:
- 62%的参与者报告说药物沟通不清楚,29%的人认为缺乏基本信息.
- 担忧包括了解副作用,药物"按需要"的使用时间和持续时间.
- 发现了处方准确性 (9%) 和药房配送 (12%) 的问题,以及轻微的接入障碍 (运输,供应,成本).
结论:
- 老年人和护理人员经常表达对药物沟通和退院后获取药物的担忧.
- 系统性改进是必要的,以加强药物管理流程.
- 减少与药物相关的危害需要解决已识别的沟通和访问差距.
相关概念视频
Drug Dosing: Geriatric Patients
339
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
339
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
302
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
302
Pharmacodynamics in Geriatric Patients: Effects of Age
307
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
307
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
291
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
291
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
783
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
783
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
307
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
307
